Original Investigation2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. Maehara has received grant support from Abbott Vascular and Boston Scientific; and has served as a consultant for Conavi Medical Inc. Dr. Stone has served as a consultant to and has equity in SpectraWave. Dr. Brilakis has received consulting/speaker honoraria from Abbott Vascular, American Heart Association (Associate Editor for Circulation), Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), CSI, Elsevier, GE Healthcare, InfraRedx, Medtronic, and Teleflex; has received research support from Regeneron and Siemens; and is a shareholder of MHI Ventures. Dr. Shunk has served as a consultant for Terumo, TransAortic Medical, and PercAssist Inc.; has equity in TransAortic Medical and PercAssist; and has received institutional grant support from Svelte, Siemens, CardioVascular Systems Inc., and Sanofi. Dr. Maini has served on the Advisory Board, received Speakers Bureau honoraria, and has served as consultant for Abbott Vascular, Medtronic, Boston Scientific, and Siemens; and has equity in East End Medical. Dr. Petersen has served on the Speakers Bureau of CSI, Inc.; has received research grants from CSI, Inc., Bristol-Myers Squibb/Pfizer, and National Institutes of Health SBIR sub-award from Veravanti; has received educational grants from Abbott Vascular, Boston Scientific, Phillips, Bristol-Myers Squibb/Pfizer, Janssen, Novartis, and AstraZeneca; has served as a research investigator/clinical trial participant for Keystone Heart, CSI Inc., Abbott Vascular, Boston Scientific, Abiomed, Svelte Medical, Niech Medical, and Novartis; and has stock/ownership in Veravanti. Dr. Généreux has received speaker fees from Abbott Vascular, Edwards Lifesciences, Medtronic, Tryton Medical Inc., Cardinal Health, and Cardiovascular Systems Inc.; has received consulting fees from Abbott Vascular, Boston Scientific, Cardiovascular Systems Inc., and Pi-Cardia; has received institutional research grants from Boston Scientific; and has equity in SIG.NUM, SoundBite Medical Solutions Inc., Saranas, and Pi-Cardia. Dr. Shah is an employee of InfraReDx. Dr. Nicholls has received research support from AstraZeneca, Amgen, Eli Lilly, Novartis, Resverlogix, InfraReDx, Sanofi-Regeneron, and Cerenis; and has served as a consultant for AstraZeneca, Amgen, Boehringer Ingelheim, CSL Behring, Akcea, Cerenis, Eli Lilly, Kowa, Novartis, Merck, Pfizer, Takeda, and Sanofi-Regeneron. Dr. Mintz has received honoraria from Boston Scientific/Philips. Dr. Muller has served as a consultant for SpectraWAVE, Inc. Dr. Weisz has served as an Advisory Board member for Corindus, Filterlex, and TriSol; and has received institutional grant support from Abbott, Ancora, Corindus, CSI, Shock Wave, Svelte, and V-Wave. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Steven E. Nissen, MD, served as Guest Associate Editor for this paper.